148 related articles for article (PubMed ID: 38126124)
1. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
[TBL] [Abstract][Full Text] [Related]
2. An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma.
Pierce JS; Ruestow PS; Finley BL
Crit Rev Toxicol; 2016 Aug; 46(7):561-86. PubMed ID: 27031024
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of mesothelioma and lung cancer risk based on Phase Contrast Microscopy (PCM) estimates of fibre exposure: an update of 2000 asbestos cohort data.
Darnton L
Environ Res; 2023 Aug; 230():114753. PubMed ID: 36965802
[TBL] [Abstract][Full Text] [Related]
4. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
5. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
Dufresne A; Harrigan M; Massé S; Bégin R
Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
[TBL] [Abstract][Full Text] [Related]
6. Asbestos in the lungs of persons exposed in the USA.
Langer AM; Nolan RP
Monaldi Arch Chest Dis; 1998 Apr; 53(2):168-80. PubMed ID: 9689804
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
8. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
Garabrant DH; Pastula ST
Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of mesothelioma in historical context.
McDonald JC; McDonald AD
Eur Respir J; 1996 Sep; 9(9):1932-42. PubMed ID: 8880114
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
[TBL] [Abstract][Full Text] [Related]
11. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden.
Gilham C; Rake C; Burdett G; Nicholson AG; Davison L; Franchini A; Carpenter J; Hodgson J; Darnton A; Peto J
Occup Environ Med; 2016 May; 73(5):290-9. PubMed ID: 26715106
[TBL] [Abstract][Full Text] [Related]
12. The presence of erionite in North American geologies and the estimated mesothelioma potency by region.
Stevens ME; Paustenbach DJ; Lockhart NJ; Busboom DE; Deckard BM; Brew DW
Inhal Toxicol; 2024 Mar; 36(3):158-173. PubMed ID: 38583132
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the exposure, dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO
Bernstein DM; Toth B; Rogers RA; Kling DE; Kunzendorf P; Phillips JI; Ernst H
Toxicol Appl Pharmacol; 2020 Jan; 387():114856. PubMed ID: 31836523
[TBL] [Abstract][Full Text] [Related]
14. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
Nicholson WJ; Raffn E
Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
[TBL] [Abstract][Full Text] [Related]
15. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
Hodgson JT; Darnton A
Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
[TBL] [Abstract][Full Text] [Related]
16. Chrysotile, tremolite, and malignant mesothelioma in man.
Churg A
Chest; 1988 Mar; 93(3):621-8. PubMed ID: 2830081
[TBL] [Abstract][Full Text] [Related]
17. Mesothelioma and analysis of tissue fiber content.
Neumann V; Löseke S; Tannapfel A
Recent Results Cancer Res; 2011; 189():79-95. PubMed ID: 21479897
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO
Bernstein DM; Toth B; Rogers RA; Kling DE; Kunzendorf P; Phillips JI; Ernst H
Toxicol Appl Pharmacol; 2020 Jan; 387():114847. PubMed ID: 31830492
[TBL] [Abstract][Full Text] [Related]
19. Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment.
Dement JM; Loomis D
Am J Ind Med; 2023 Jul; 66(7):543-553. PubMed ID: 36974955
[TBL] [Abstract][Full Text] [Related]
20. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
